Document Detail

Effects of cGMP on L-type calcium current of adult and newborn rabbit ventricular cells.
MedLine Citation:
PMID:  9093527     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: Cyclic GMP has been shown to be in some respects an inhibitory modulator of heart function. Various studies on the modulation of cardiac L-type calcium current (ICa) by cGMP in different species show inconsistency and the role of cGMP remains unclear and controversial. The present study was focused on the differences in the modulation of basal ICa by cGMP in adult and newborn rabbit ventricular cells. METHODS: Enzymatically isolated adult and newborn (1-4-day-old) rabbit ventricular myocytes were used to measure ICa under whole-cell voltage clamp conditions with internal perfusion of isolated cells. RESULTS: We have shown that in adult ventricular cells, the intracellular perfusion of 8BrcGMP did not produce any effect on basal ICa, while intracellular perfusion of 8BrcGMP or 8CPT-cGMP in newborn ventricular cells significantly and reversibly increased basal ICa without changing the voltage dependence for activation of ICa. Both methylene blue and LY-83583 (which inhibit guanylyl cyclase and thus lower cGMP levels), in adult ventricular cells, failed to produce any significant effect on basal ICa, while in newborn ventricular cells the application of methylene blue or LY-83583 produced irreversible inhibition of basal ICa. Similarly, KT-5823, an inhibitor of cGMP-dependent protein kinase, also inhibited basal ICa in newborn ventricular cells but not in adult ventricular cells. However, extracellular application of methylene blue during the intracellular perfusion of 8BrcGMP was unable to inhibit ICa. Extracellular application of nitrosoglutathione which releases nitric oxide produced a significant increase in ICa in newborn but not in adult ventricular cells. Intracellular application of a cAMP-dependent protein kinase inhibitor peptide blocked the stimulatory effect of cAMP but not of 8CPT-cGMP, while the stimulatory effect of nitrosoglutathione on ICa was not blocked by the presence of a phosphodiesterase inhibitor (isobutylmethyl-xanthine). CONCLUSIONS: We propose that, for newborn rabbit ventricular cells, cGMP plays a crucial role in maintaining basal ICa by a mechanism mediated via protein-kinase-G-dependent phosphorylation of calcium channels or some associated protein.
R Kumar; T Namiki; R W Joyner
Related Documents :
3016277 - Formation of extracellular cgmp in blood mononuclear and platelet cell preparations.
19053017 - Rhusonoside a, a new megastigmane glycoside from rhus sylvestris, increases the functio...
4030257 - Measurement of centripetal migration of normal corneal epithelial cells in the mouse.
3156177 - Abscissic acid localization by light microscopic immunohistochemistry in chenopodium po...
20861257 - Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin/bst-2-mediat...
9626587 - Direct, real-time sensing of free radical production by activated human glioblastoma ce...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Cardiovascular research     Volume:  33     ISSN:  0008-6363     ISO Abbreviation:  Cardiovasc. Res.     Publication Date:  1997 Mar 
Date Detail:
Created Date:  1997-06-09     Completed Date:  1997-06-09     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0077427     Medline TA:  Cardiovasc Res     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  573-82     Citation Subset:  IM    
Todd Franklin Cardiac Research Laboratory, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
1-Methyl-3-isobutylxanthine / pharmacology
Alkaloids / pharmacology
Aminoquinolines / pharmacology
Animals, Newborn / metabolism*
Calcium / metabolism
Calcium Channels / drug effects*
Cells, Cultured
Cyclic GMP / analogs & derivatives*,  pharmacology
Cyclic GMP-Dependent Protein Kinases / antagonists & inhibitors
Glutathione / analogs & derivatives,  pharmacology
Guanylate Cyclase / antagonists & inhibitors
Methylene Blue / pharmacology
Myocardium / metabolism*
Nitroso Compounds / pharmacology
Patch-Clamp Techniques
Phosphodiesterase Inhibitors / pharmacology
Protein Kinase Inhibitors
Thionucleotides / pharmacology
Time Factors
Grant Support
Reg. No./Substance:
0/8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate; 0/Alkaloids; 0/Aminoquinolines; 0/Calcium Channels; 0/Carbazoles; 0/Indoles; 0/Nitroso Compounds; 0/Phosphodiesterase Inhibitors; 0/Protein Kinase Inhibitors; 0/Thionucleotides; 126643-37-6/KT 5823; 28822-58-4/1-Methyl-3-isobutylxanthine; 31356-94-2/8-bromocyclic GMP; 57564-91-7/S-Nitrosoglutathione; 61-73-4/Methylene Blue; 70-18-8/Glutathione; 7440-70-2/Calcium; 7665-99-8/Cyclic GMP; 91300-60-6/6-anilino-5,8-quinolinedione; EC GMP-Dependent Protein Kinases; EC Cyclase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Wall stress-induced arrhythmias in the working rat heart as left ventricular hypertrophy regresses d...
Next Document:  Comparative study of the biomechanical performance of trained and untrained skeletal muscle.